查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464904

血液凝固检验市场：按产品类型、测试类型、最终用户划分 - 2024-2030 年全球预测

Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

血液凝固检验市场规模预计2023年为46.2亿美元，2024年达50.7亿美元，预计2030年将达到89.6亿美元，复合年增长率为9.92%。

血液凝固检验涉及一系列旨在评估血液正常凝固能力的诊断程序。这些检查对于诊断和治疗影响血液凝固的各种疾病至关重要，例如血友病、血栓症和肝臟疾病。监测接受抗凝血治疗的患者也很重要，以确保安全有效的治疗结果。心血管和血液疾病的盛行率不断增加，导致越来越多地采用血液凝固检验。此外，世界人口老化，血液相关疾病的风险更高，也显着增加了对血液凝固检验的需求。然而，血液凝固检验设备的高成本和新设备核准的严格监管要求正在推迟产品上市并影响市场动态。儘管面临这些挑战，新兴国家仍在增加对医疗基础设施的投资，未来的成长是可期的。此外，旨在引入创新且高效的 KEYWORD 解决方案的研发活动正在进行中，并且预计会出现新的扩展途径。

主要市场统计
基准年[2023] 46.2亿美元
预测年份 [2024] 50.7亿美元
预测年份 [2030] 89.6亿美元
复合年增长率（%） 9.92%

更多采用自动化设备，以提高产品血液凝固检验的效率和扩充性

血液凝固检验中的耗材包括试剂、试纸等血液凝固检验必需的一次性材料。这些对于准确检测和测量凝血时间、因子和其他相关参数至关重要。血液凝固检验设备范围从基本的手动设备到全自动系统。这些设备用于各种测试，包括凝血酶原时间 (PT) 和活化部份凝血活酵素时间(aPTT)。手动或自动系统之间的选择通常基于实验室执行的测试量和所需测试的复杂性。

最终用户：越来越多地采用支援远端患者监护的家庭血液凝固检验套件

临床实验室代表了血液凝固检验市场的重要部分。这些设施需要全面、先进的血液凝固检验解决方案，为各种出血和凝血障碍提供准确、可靠的诊断服务。临床实验室更喜欢能够高效处理大量检体的高通量凝血分析仪。人们越来越重视以患者为中心的护理，并且需要持续监测接受抗凝血治疗的患者，这推动了对居家血液凝固检验检测解决方案的需求。家用检测套组对于寻求便利且对日常生活影响最小的患者很有吸引力。医院需要多种血液凝固检验能力，以满足从急诊室到凝血门诊等各科室的需求。该产业青睐多功能、快速的凝血分析仪，能够在急诊环境中快速做出决策。

区域洞察

血液凝固检验的采用在美洲越来越多，尤其是在心血管疾病盛行率高且人口老化的北美。美国的采用率很高，得益于先进的医疗基础设施和优惠的报销政策。欧洲、中东和非洲地区的血液凝固检验市场呈现多样化的情况，其中欧洲的采用率很高。欧洲的成长得益于越来越多地采用现场检测设备以实现更快、更有效率的诊断，以及强大的医疗保健系统和患者的高水平意识。由于政府和非政府组织改善医疗设施的倡议，中东和非洲正在经历适度成长。在快速发展的医疗基础设施和庞大的患者群的推动下，亚太地区预计将成为最大的血液凝固检验市场。在中国和印度等国家，随着中产阶级人口的增长和对医疗改革兴趣的增加，血液凝固检验的采用正走在最前线。此外，该地区不断增长的开发负担得起的测试解决方案的研发活动预计也将提振该地区的市场。

FPNV定位矩阵

FPNV定位矩阵对于评估血液凝固检验市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对血液凝固检验市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.血液凝固检验市场规模及预测是多少？

2.在血液凝固检验市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.血液凝固检验市场的技术趋势和法规结构是什么？

4.血液凝固检验市场主要厂商的市场占有率是多少？

5.进入血液凝固检验市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球凝血病患病率增加
      • 政府宣传活动，提高人们对危及生命的血栓的认识
    • 抑制因素
      • 血液凝固检验缺乏报销
    • 机会
      • 血液凝固检验技术的进展
      • 居家照护血液凝固检验的出现
    • 任务
      • 血液凝固检验的技术限制与不准确性
  • 市场区隔分析
    • 产品：更多采用自动化设备，以实现血液凝固检验的效率和扩充性
    • 最终用户：越来越多地采用支援远端患者监护的家庭血液凝固检验套件
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章血液凝固检验市场：副产品

  • 消耗品
  • 装置

第七章按测试类型血液凝固检验市场

  • 活化部份凝血活酵素时间
  • 凝血酶原时间
  • 凝血酶时间

第 8 章血液凝固检验市场：依最终用户分类

  • 临床实验室
  • 家庭测试
  • 医院

第九章 北美、南美血液凝固检验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太血液凝固检验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲血液凝固检验市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 罗氏推出三款新的 Xa 因子抑制剂血液凝固检验，以满足不断增长的患者需求
    • HORIBA UK 在 2023 年 IBMS 会议上宣布推出新型全自动凝血分析仪
    • Diagnostica Stago 凝血分析仪获得 FDA 510(k) 许可
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-BF590674206B

[192 Pages Report] The Coagulation Testing Market size was estimated at USD 4.62 billion in 2023 and expected to reach USD 5.07 billion in 2024, at a CAGR 9.92% to reach USD 8.96 billion by 2030.

Coagulation testing encompasses a range of diagnostic procedures aimed at assessing the blood's ability to clot properly. These tests are critical in diagnosing and managing various conditions that affect the blood's clotting capability, such as hemophilia, thrombosis, and liver disease. They are also essential in monitoring patients on anticoagulation therapy to ensure safe and effective treatment outcomes. The rising prevalence of cardiovascular diseases and blood disorders has increased the adoption of coagulation testing. Additionally, the aging global population at higher risk of blood-related disorders also significantly raises the need for coagulation testing. However, the high cost of coagulation testing devices and stringent regulatory requirements for the new devices' approval delay product launches, affecting market dynamics. Despite these challenges, increasing investment in healthcare infrastructure in emerging economies provides a future growth prospect. Furthermore, ongoing research and development activities aiming to introduce innovative and efficient coagulation testing solutions are expected to offer new avenues for expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 4.62 billion
Estimated Year [2024] USD 5.07 billion
Forecast Year [2030] USD 8.96 billion
CAGR (%) 9.92%

Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing

Consumables in coagulation testing include reagents, test strips, and other single-use materials integral to conducting a coagulation test. These are essential for accurately detecting and measuring blood clotting times, factors, and other related parameters. Coagulation testing instruments range from basic manual devices to fully automated systems. These machines are used for various tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), and more. The choice between manual and automated systems is generally based on the volume of tests a laboratory performs and the complexity of the tests required.

End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring

Clinical laboratories represent a significant segment of the coagulation testing market. These facilities require comprehensive and advanced coagulation testing solutions to offer accurate and reliable diagnostic services for a variety of bleeding and clotting disorders. The preference in clinical laboratories leans towards high-throughput coagulation analyzers that can handle a large volume of samples efficiently. The demand for home testing solutions in coagulation testing has surged, driven by the increasing emphasis on patient-centered care and the need for continuous monitoring of patients on anticoagulation therapy. Home testing kits appeal to patients seeking convenience and minimal disruption to daily life. Hospitals require a diverse range of coagulation testing capabilities to cater to the needs of different departments, from emergency rooms to specialized coagulation clinics. The preference in this segment is for versatile and rapid coagulation analyzers that facilitate quick decision-making in acute care settings.

Regional Insights

In the Americas, coagulation testing is getting highly adopted owing to the high prevalence of cardiovascular diseases and an increasing aging population, particularly in North America. The United States showcases higher adoption, supported by advanced healthcare infrastructure and favorable reimbursement policies. The EMEA region presents diverse scenarios in the coagulation testing market, with Europe having a high adoption rate. The growth in Europe is spurred by the increasing adoption of point-of-care (POC) testing devices for faster and more efficient diagnosis, alongside strong healthcare systems and a higher level of patient awareness. The Middle East and Africa are witnessing gradual growth, with initiatives by governments and NGOs to improve healthcare facilities. Asia-Pacific is projected to be the biggest market for coagulation testing, driven by rapidly developing healthcare infrastructure and a large patient pool. Countries inclduing China and India are at the forefront of the adoption of coagulation testing, with their growing middle-class populations and increased focus on healthcare reform. Furthermore, the expanding research and development activities in the region to develop affordable testing solutions are expected to boost the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

Market Segmentation & Coverage

This research report categorizes the Coagulation Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instruments
  • Test Type
    • Activated Partial Thromboplastin Time
    • Prothrombin Time
    • Thrombin Time
  • End-User
    • Clinical Laboratories
    • Home Testing
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Coagulation Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Testing Market?

3. What are the technology trends and regulatory frameworks in the Coagulation Testing Market?

4. What is the market share of the leading vendors in the Coagulation Testing Market?

5. Which modes and strategic moves are suitable for entering the Coagulation Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of coagulation disorders worldwide
      • 5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for coagulation testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in coagulation testing technologies
      • 5.1.3.2. Emergence of coagulation testing for homecare
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and inaccuracies of coagulation testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
    • 5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Coagulation Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Coagulation Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Activated Partial Thromboplastin Time
  • 7.3. Prothrombin Time
  • 7.4. Thrombin Time

8. Coagulation Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Laboratories
  • 8.3. Home Testing
  • 8.4. Hospitals

9. Americas Coagulation Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coagulation Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coagulation Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
    • 12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
    • 12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COAGULATION TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023